Summit Therapeutics Inc (SMMT)
NASDAQ · Biotechnology
Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.
Price history
Daily closes and volumeAI Analysis Generated from the indicator readings below. Educational only.
Summit Therapeutics Inc is trading at $13.02, up 1.56% on the session. The 50 day average sits at $14.24 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 43.3, which reads as weak, and MACD is bullish crossover. Volume is volume spike.
The nearest support is around $12.55 with resistance near $14.81, so that band frames the current range. Average daily movement is roughly $0.86, or about 6.6% of the share price, which is what any stop placement has to allow for. The overall health score of 43 out of 100 combines a trend score of 25, momentum of 60 and a risk score of 48.